Sign in
4

Changes in Ownership

PULSE BIOSCIENCES, INC. Filed Acc 0001437749-26-003840

Chief Commercial Officer sold 60,000 shares at an average $23.39 ($1,403,400)

  • Chief Commercial Officer acquired 60,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Danahy Kevin Patrick Chief Commercial Officer 2026-02-09 Option exercise 10b5-1 +20,000 $1.53 $30,600 63,298 D: show line 1 in the form
Danahy Kevin Patrick Chief Commercial Officer 2026-02-09 Sale 10b5-1 −20,000 $21.45 $429,000 43,298 D: show line 2 in the form
Danahy Kevin Patrick Chief Commercial Officer 2026-02-10 Option exercise 10b5-1 +20,000 $1.53 $30,600 63,298 D: show line 3 in the form
Danahy Kevin Patrick Chief Commercial Officer 2026-02-10 Sale 10b5-1 −20,000 $23.52 $470,400 43,298 D: show line 4 in the form
Danahy Kevin Patrick Chief Commercial Officer 2026-02-11 Option exercise 10b5-1 +20,000 $1.53 $30,600 63,298 D: show line 5 in the form
Danahy Kevin Patrick Chief Commercial Officer 2026-02-11 Sale 10b5-1 −20,000 $25.20 $504,000 43,298 D: show line 6 in the form
Open-market sales · 60,000 sh · avg $23.39 · $1,403,400

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Danahy Kevin Patrick Chief Commercial Officer 2026-02-09 Option exercise · Stock Option (right to buy) 10b5-1 −20,000 405,000 D: show line 7 in the form
Danahy Kevin Patrick Chief Commercial Officer 2026-02-10 Option exercise · Stock Option (right to buy) 10b5-1 −20,000 385,000 D: show line 8 in the form
Danahy Kevin Patrick Chief Commercial Officer 2026-02-11 Option exercise · Stock Option (right to buy) 10b5-1 −20,000 365,000 D: show line 9 in the form
Loading xslF345X05/rdgdoc.xml…